Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-01-05 @ 6:03 PM
Study NCT ID:
NCT01894256
Status:
COMPLETED
Last Update Posted:
2016-10-13
First Post:
2013-07-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11
Start Date Type:
None
Primary Completion Date:
2015-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-04
First Submit QC Date:
None
Study First Post Date:
2013-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-18
Results First Submit QC Date:
None
Results First Post Date:
2016-04-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-19
Last Update Post Date:
2016-10-13
Last Update Post Date Type:
ESTIMATED